カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

鼻炎薬のグローバル市場2023：抗ヒスタミン薬、点鼻ステロイド薬、抗ロイコトリエン薬

■ 英語タイトル：Global Rhinitis Medicine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR23AG11545）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR23AG11545
■ 発行日：2023年8月
■ 調査対象地域：グローバル
■ 産業分野：医薬品＆ヘルスケア
■ ページ数：107
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[鼻炎薬のグローバル市場2023：抗ヒスタミン薬、点鼻ステロイド薬、抗ロイコトリエン薬]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Global Info Research社の最新の調査によると、鼻炎薬のグローバル市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
本調査レポートは、世界の鼻炎薬市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本資料の主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- 鼻炎薬の成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

鼻炎薬市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメント
・抗ヒスタミン薬、点鼻ステロイド薬、抗ロイコトリエン薬

用途別セグメント
・アレルギー性鼻炎、感染性鼻炎、その他

主要な市場プレーヤー
・GlaxoSmithKline、Regeneron Pharmaceuticals、Neurent Medical、Lotus、Glenmark、Taiho Pharmaceutical、Hikma Pharmaceuticals、Med Globe Therapeutics Limited、Stallergenes Greer、AstraZeneca、Bayer Global

地域別セグメントは次の地域・国をカバーします。
・北米（アメリカ、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、鼻炎薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な鼻炎薬メーカーの企業概要、2019年～2022年までの鼻炎薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な鼻炎薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別鼻炎薬の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までの鼻炎薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での鼻炎薬市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および鼻炎薬の産業チェーンを掲載しています。
・第14、15章では、鼻炎薬の販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– 鼻炎薬の概要
– 種類別分析（2018年vs2022年vs2029年）：抗ヒスタミン薬、点鼻ステロイド薬、抗ロイコトリエン薬
– 用途別分析（2018年vs2022年vs2029年）：アレルギー性鼻炎、感染性鼻炎、その他
– 世界の鼻炎薬市場規模・予測
– 世界の鼻炎薬生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– GlaxoSmithKline、Regeneron Pharmaceuticals、Neurent Medical、Lotus、Glenmark、Taiho Pharmaceutical、Hikma Pharmaceuticals、Med Globe Therapeutics Limited、Stallergenes Greer、AstraZeneca、Bayer Global
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：抗ヒスタミン薬、点鼻ステロイド薬、抗ロイコトリエン薬
・用途別分析2018年-2029年：アレルギー性鼻炎、感染性鼻炎、その他
・鼻炎薬の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・鼻炎薬のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・鼻炎薬のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・鼻炎薬の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・鼻炎薬の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Product Overview and Scope of Rhinitis Medicine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Rhinitis Medicine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Antihistamines
1.3.3 Nasal Spray Steroids
1.3.4 Antileukotrienes
1.4 Market Analysis by Application
1.4.1 Overview: Global Rhinitis Medicine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Allergic Rhinitis
1.4.3 Infectious Rhinitis
1.4.4 Others
1.5 Global Rhinitis Medicine Market Size & Forecast
1.5.1 Global Rhinitis Medicine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Rhinitis Medicine Sales Quantity (2018-2029)
1.5.3 Global Rhinitis Medicine Average Price (2018-2029)
2 Manufacturers Profiles
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business
2.1.3 GlaxoSmithKline Rhinitis Medicine Product and Services
2.1.4 GlaxoSmithKline Rhinitis Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 GlaxoSmithKline Recent Developments/Updates
2.2 Regeneron Pharmaceuticals
2.2.1 Regeneron Pharmaceuticals Details
2.2.2 Regeneron Pharmaceuticals Major Business
2.2.3 Regeneron Pharmaceuticals Rhinitis Medicine Product and Services
2.2.4 Regeneron Pharmaceuticals Rhinitis Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Regeneron Pharmaceuticals Recent Developments/Updates
2.3 Neurent Medical
2.3.1 Neurent Medical Details
2.3.2 Neurent Medical Major Business
2.3.3 Neurent Medical Rhinitis Medicine Product and Services
2.3.4 Neurent Medical Rhinitis Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Neurent Medical Recent Developments/Updates
2.4 Lotus
2.4.1 Lotus Details
2.4.2 Lotus Major Business
2.4.3 Lotus Rhinitis Medicine Product and Services
2.4.4 Lotus Rhinitis Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Lotus Recent Developments/Updates
2.5 Glenmark
2.5.1 Glenmark Details
2.5.2 Glenmark Major Business
2.5.3 Glenmark Rhinitis Medicine Product and Services
2.5.4 Glenmark Rhinitis Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Glenmark Recent Developments/Updates
2.6 Taiho Pharmaceutical
2.6.1 Taiho Pharmaceutical Details
2.6.2 Taiho Pharmaceutical Major Business
2.6.3 Taiho Pharmaceutical Rhinitis Medicine Product and Services
2.6.4 Taiho Pharmaceutical Rhinitis Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Taiho Pharmaceutical Recent Developments/Updates
2.7 Hikma Pharmaceuticals
2.7.1 Hikma Pharmaceuticals Details
2.7.2 Hikma Pharmaceuticals Major Business
2.7.3 Hikma Pharmaceuticals Rhinitis Medicine Product and Services
2.7.4 Hikma Pharmaceuticals Rhinitis Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Hikma Pharmaceuticals Recent Developments/Updates
2.8 Med Globe Therapeutics Limited
2.8.1 Med Globe Therapeutics Limited Details
2.8.2 Med Globe Therapeutics Limited Major Business
2.8.3 Med Globe Therapeutics Limited Rhinitis Medicine Product and Services
2.8.4 Med Globe Therapeutics Limited Rhinitis Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Med Globe Therapeutics Limited Recent Developments/Updates
2.9 Stallergenes Greer
2.9.1 Stallergenes Greer Details
2.9.2 Stallergenes Greer Major Business
2.9.3 Stallergenes Greer Rhinitis Medicine Product and Services
2.9.4 Stallergenes Greer Rhinitis Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Stallergenes Greer Recent Developments/Updates
2.10 AstraZeneca
2.10.1 AstraZeneca Details
2.10.2 AstraZeneca Major Business
2.10.3 AstraZeneca Rhinitis Medicine Product and Services
2.10.4 AstraZeneca Rhinitis Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 AstraZeneca Recent Developments/Updates
2.11 Bayer Global
2.11.1 Bayer Global Details
2.11.2 Bayer Global Major Business
2.11.3 Bayer Global Rhinitis Medicine Product and Services
2.11.4 Bayer Global Rhinitis Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Bayer Global Recent Developments/Updates
3 Competitive Environment: Rhinitis Medicine by Manufacturer
3.1 Global Rhinitis Medicine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Rhinitis Medicine Revenue by Manufacturer (2018-2023)
3.3 Global Rhinitis Medicine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Rhinitis Medicine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Rhinitis Medicine Manufacturer Market Share in 2022
3.4.2 Top 6 Rhinitis Medicine Manufacturer Market Share in 2022
3.5 Rhinitis Medicine Market: Overall Company Footprint Analysis
3.5.1 Rhinitis Medicine Market: Region Footprint
3.5.2 Rhinitis Medicine Market: Company Product Type Footprint
3.5.3 Rhinitis Medicine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Rhinitis Medicine Market Size by Region
4.1.1 Global Rhinitis Medicine Sales Quantity by Region (2018-2029)
4.1.2 Global Rhinitis Medicine Consumption Value by Region (2018-2029)
4.1.3 Global Rhinitis Medicine Average Price by Region (2018-2029)
4.2 North America Rhinitis Medicine Consumption Value (2018-2029)
4.3 Europe Rhinitis Medicine Consumption Value (2018-2029)
4.4 Asia-Pacific Rhinitis Medicine Consumption Value (2018-2029)
4.5 South America Rhinitis Medicine Consumption Value (2018-2029)
4.6 Middle East and Africa Rhinitis Medicine Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Rhinitis Medicine Sales Quantity by Type (2018-2029)
5.2 Global Rhinitis Medicine Consumption Value by Type (2018-2029)
5.3 Global Rhinitis Medicine Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Rhinitis Medicine Sales Quantity by Application (2018-2029)
6.2 Global Rhinitis Medicine Consumption Value by Application (2018-2029)
6.3 Global Rhinitis Medicine Average Price by Application (2018-2029)
7 North America
7.1 North America Rhinitis Medicine Sales Quantity by Type (2018-2029)
7.2 North America Rhinitis Medicine Sales Quantity by Application (2018-2029)
7.3 North America Rhinitis Medicine Market Size by Country
7.3.1 North America Rhinitis Medicine Sales Quantity by Country (2018-2029)
7.3.2 North America Rhinitis Medicine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Rhinitis Medicine Sales Quantity by Type (2018-2029)
8.2 Europe Rhinitis Medicine Sales Quantity by Application (2018-2029)
8.3 Europe Rhinitis Medicine Market Size by Country
8.3.1 Europe Rhinitis Medicine Sales Quantity by Country (2018-2029)
8.3.2 Europe Rhinitis Medicine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Rhinitis Medicine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Rhinitis Medicine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Rhinitis Medicine Market Size by Region
9.3.1 Asia-Pacific Rhinitis Medicine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Rhinitis Medicine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Rhinitis Medicine Sales Quantity by Type (2018-2029)
10.2 South America Rhinitis Medicine Sales Quantity by Application (2018-2029)
10.3 South America Rhinitis Medicine Market Size by Country
10.3.1 South America Rhinitis Medicine Sales Quantity by Country (2018-2029)
10.3.2 South America Rhinitis Medicine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Rhinitis Medicine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Rhinitis Medicine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Rhinitis Medicine Market Size by Country
11.3.1 Middle East & Africa Rhinitis Medicine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Rhinitis Medicine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Rhinitis Medicine Market Drivers
12.2 Rhinitis Medicine Market Restraints
12.3 Rhinitis Medicine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Rhinitis Medicine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Rhinitis Medicine
13.3 Rhinitis Medicine Production Process
13.4 Rhinitis Medicine Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Rhinitis Medicine Typical Distributors
14.3 Rhinitis Medicine Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Rhinitis Medicine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Rhinitis Medicine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 4. GlaxoSmithKline Major Business
Table 5. GlaxoSmithKline Rhinitis Medicine Product and Services
Table 6. GlaxoSmithKline Rhinitis Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. GlaxoSmithKline Recent Developments/Updates
Table 8. Regeneron Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 9. Regeneron Pharmaceuticals Major Business
Table 10. Regeneron Pharmaceuticals Rhinitis Medicine Product and Services
Table 11. Regeneron Pharmaceuticals Rhinitis Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Regeneron Pharmaceuticals Recent Developments/Updates
Table 13. Neurent Medical Basic Information, Manufacturing Base and Competitors
Table 14. Neurent Medical Major Business
Table 15. Neurent Medical Rhinitis Medicine Product and Services
Table 16. Neurent Medical Rhinitis Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Neurent Medical Recent Developments/Updates
Table 18. Lotus Basic Information, Manufacturing Base and Competitors
Table 19. Lotus Major Business
Table 20. Lotus Rhinitis Medicine Product and Services
Table 21. Lotus Rhinitis Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Lotus Recent Developments/Updates
Table 23. Glenmark Basic Information, Manufacturing Base and Competitors
Table 24. Glenmark Major Business
Table 25. Glenmark Rhinitis Medicine Product and Services
Table 26. Glenmark Rhinitis Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Glenmark Recent Developments/Updates
Table 28. Taiho Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 29. Taiho Pharmaceutical Major Business
Table 30. Taiho Pharmaceutical Rhinitis Medicine Product and Services
Table 31. Taiho Pharmaceutical Rhinitis Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Taiho Pharmaceutical Recent Developments/Updates
Table 33. Hikma Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 34. Hikma Pharmaceuticals Major Business
Table 35. Hikma Pharmaceuticals Rhinitis Medicine Product and Services
Table 36. Hikma Pharmaceuticals Rhinitis Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Hikma Pharmaceuticals Recent Developments/Updates
Table 38. Med Globe Therapeutics Limited Basic Information, Manufacturing Base and Competitors
Table 39. Med Globe Therapeutics Limited Major Business
Table 40. Med Globe Therapeutics Limited Rhinitis Medicine Product and Services
Table 41. Med Globe Therapeutics Limited Rhinitis Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Med Globe Therapeutics Limited Recent Developments/Updates
Table 43. Stallergenes Greer Basic Information, Manufacturing Base and Competitors
Table 44. Stallergenes Greer Major Business
Table 45. Stallergenes Greer Rhinitis Medicine Product and Services
Table 46. Stallergenes Greer Rhinitis Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Stallergenes Greer Recent Developments/Updates
Table 48. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 49. AstraZeneca Major Business
Table 50. AstraZeneca Rhinitis Medicine Product and Services
Table 51. AstraZeneca Rhinitis Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. AstraZeneca Recent Developments/Updates
Table 53. Bayer Global Basic Information, Manufacturing Base and Competitors
Table 54. Bayer Global Major Business
Table 55. Bayer Global Rhinitis Medicine Product and Services
Table 56. Bayer Global Rhinitis Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Bayer Global Recent Developments/Updates
Table 58. Global Rhinitis Medicine Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 59. Global Rhinitis Medicine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 60. Global Rhinitis Medicine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 61. Market Position of Manufacturers in Rhinitis Medicine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 62. Head Office and Rhinitis Medicine Production Site of Key Manufacturer
Table 63. Rhinitis Medicine Market: Company Product Type Footprint
Table 64. Rhinitis Medicine Market: Company Product Application Footprint
Table 65. Rhinitis Medicine New Market Entrants and Barriers to Market Entry
Table 66. Rhinitis Medicine Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Rhinitis Medicine Sales Quantity by Region (2018-2023) & (K Units)
Table 68. Global Rhinitis Medicine Sales Quantity by Region (2024-2029) & (K Units)
Table 69. Global Rhinitis Medicine Consumption Value by Region (2018-2023) & (USD Million)
Table 70. Global Rhinitis Medicine Consumption Value by Region (2024-2029) & (USD Million)
Table 71. Global Rhinitis Medicine Average Price by Region (2018-2023) & (US$/Unit)
Table 72. Global Rhinitis Medicine Average Price by Region (2024-2029) & (US$/Unit)
Table 73. Global Rhinitis Medicine Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Global Rhinitis Medicine Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Global Rhinitis Medicine Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Global Rhinitis Medicine Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Global Rhinitis Medicine Average Price by Type (2018-2023) & (US$/Unit)
Table 78. Global Rhinitis Medicine Average Price by Type (2024-2029) & (US$/Unit)
Table 79. Global Rhinitis Medicine Sales Quantity by Application (2018-2023) & (K Units)
Table 80. Global Rhinitis Medicine Sales Quantity by Application (2024-2029) & (K Units)
Table 81. Global Rhinitis Medicine Consumption Value by Application (2018-2023) & (USD Million)
Table 82. Global Rhinitis Medicine Consumption Value by Application (2024-2029) & (USD Million)
Table 83. Global Rhinitis Medicine Average Price by Application (2018-2023) & (US$/Unit)
Table 84. Global Rhinitis Medicine Average Price by Application (2024-2029) & (US$/Unit)
Table 85. North America Rhinitis Medicine Sales Quantity by Type (2018-2023) & (K Units)
Table 86. North America Rhinitis Medicine Sales Quantity by Type (2024-2029) & (K Units)
Table 87. North America Rhinitis Medicine Sales Quantity by Application (2018-2023) & (K Units)
Table 88. North America Rhinitis Medicine Sales Quantity by Application (2024-2029) & (K Units)
Table 89. North America Rhinitis Medicine Sales Quantity by Country (2018-2023) & (K Units)
Table 90. North America Rhinitis Medicine Sales Quantity by Country (2024-2029) & (K Units)
Table 91. North America Rhinitis Medicine Consumption Value by Country (2018-2023) & (USD Million)
Table 92. North America Rhinitis Medicine Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Europe Rhinitis Medicine Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Europe Rhinitis Medicine Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Europe Rhinitis Medicine Sales Quantity by Application (2018-2023) & (K Units)
Table 96. Europe Rhinitis Medicine Sales Quantity by Application (2024-2029) & (K Units)
Table 97. Europe Rhinitis Medicine Sales Quantity by Country (2018-2023) & (K Units)
Table 98. Europe Rhinitis Medicine Sales Quantity by Country (2024-2029) & (K Units)
Table 99. Europe Rhinitis Medicine Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Rhinitis Medicine Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Rhinitis Medicine Sales Quantity by Type (2018-2023) & (K Units)
Table 102. Asia-Pacific Rhinitis Medicine Sales Quantity by Type (2024-2029) & (K Units)
Table 103. Asia-Pacific Rhinitis Medicine Sales Quantity by Application (2018-2023) & (K Units)
Table 104. Asia-Pacific Rhinitis Medicine Sales Quantity by Application (2024-2029) & (K Units)
Table 105. Asia-Pacific Rhinitis Medicine Sales Quantity by Region (2018-2023) & (K Units)
Table 106. Asia-Pacific Rhinitis Medicine Sales Quantity by Region (2024-2029) & (K Units)
Table 107. Asia-Pacific Rhinitis Medicine Consumption Value by Region (2018-2023) & (USD Million)
Table 108. Asia-Pacific Rhinitis Medicine Consumption Value by Region (2024-2029) & (USD Million)
Table 109. South America Rhinitis Medicine Sales Quantity by Type (2018-2023) & (K Units)
Table 110. South America Rhinitis Medicine Sales Quantity by Type (2024-2029) & (K Units)
Table 111. South America Rhinitis Medicine Sales Quantity by Application (2018-2023) & (K Units)
Table 112. South America Rhinitis Medicine Sales Quantity by Application (2024-2029) & (K Units)
Table 113. South America Rhinitis Medicine Sales Quantity by Country (2018-2023) & (K Units)
Table 114. South America Rhinitis Medicine Sales Quantity by Country (2024-2029) & (K Units)
Table 115. South America Rhinitis Medicine Consumption Value by Country (2018-2023) & (USD Million)
Table 116. South America Rhinitis Medicine Consumption Value by Country (2024-2029) & (USD Million)
Table 117. Middle East & Africa Rhinitis Medicine Sales Quantity by Type (2018-2023) & (K Units)
Table 118. Middle East & Africa Rhinitis Medicine Sales Quantity by Type (2024-2029) & (K Units)
Table 119. Middle East & Africa Rhinitis Medicine Sales Quantity by Application (2018-2023) & (K Units)
Table 120. Middle East & Africa Rhinitis Medicine Sales Quantity by Application (2024-2029) & (K Units)
Table 121. Middle East & Africa Rhinitis Medicine Sales Quantity by Region (2018-2023) & (K Units)
Table 122. Middle East & Africa Rhinitis Medicine Sales Quantity by Region (2024-2029) & (K Units)
Table 123. Middle East & Africa Rhinitis Medicine Consumption Value by Region (2018-2023) & (USD Million)
Table 124. Middle East & Africa Rhinitis Medicine Consumption Value by Region (2024-2029) & (USD Million)
Table 125. Rhinitis Medicine Raw Material
Table 126. Key Manufacturers of Rhinitis Medicine Raw Materials
Table 127. Rhinitis Medicine Typical Distributors
Table 128. Rhinitis Medicine Typical Customers
List of Figures
Figure 1. Rhinitis Medicine Picture
Figure 2. Global Rhinitis Medicine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Rhinitis Medicine Consumption Value Market Share by Type in 2022
Figure 4. Antihistamines Examples
Figure 5. Nasal Spray Steroids Examples
Figure 6. Antileukotrienes Examples
Figure 7. Global Rhinitis Medicine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Rhinitis Medicine Consumption Value Market Share by Application in 2022
Figure 9. Allergic Rhinitis Examples
Figure 10. Infectious Rhinitis Examples
Figure 11. Others Examples
Figure 12. Global Rhinitis Medicine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Rhinitis Medicine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Rhinitis Medicine Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Rhinitis Medicine Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Rhinitis Medicine Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Rhinitis Medicine Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Rhinitis Medicine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Rhinitis Medicine Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Rhinitis Medicine Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Rhinitis Medicine Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Rhinitis Medicine Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Rhinitis Medicine Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Rhinitis Medicine Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Rhinitis Medicine Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Rhinitis Medicine Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Rhinitis Medicine Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Rhinitis Medicine Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Rhinitis Medicine Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Rhinitis Medicine Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Rhinitis Medicine Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Rhinitis Medicine Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Rhinitis Medicine Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Rhinitis Medicine Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Rhinitis Medicine Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Rhinitis Medicine Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Rhinitis Medicine Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Rhinitis Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Rhinitis Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Rhinitis Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Rhinitis Medicine Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Rhinitis Medicine Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Rhinitis Medicine Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Rhinitis Medicine Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Rhinitis Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Rhinitis Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Rhinitis Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Rhinitis Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Rhinitis Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Rhinitis Medicine Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Rhinitis Medicine Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Rhinitis Medicine Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Rhinitis Medicine Consumption Value Market Share by Region (2018-2029)
Figure 54. China Rhinitis Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Rhinitis Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Rhinitis Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Rhinitis Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Rhinitis Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Rhinitis Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Rhinitis Medicine Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Rhinitis Medicine Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Rhinitis Medicine Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Rhinitis Medicine Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Rhinitis Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Rhinitis Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Rhinitis Medicine Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Rhinitis Medicine Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Rhinitis Medicine Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Rhinitis Medicine Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Rhinitis Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Rhinitis Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Rhinitis Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Rhinitis Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Rhinitis Medicine Market Drivers
Figure 75. Rhinitis Medicine Market Restraints
Figure 76. Rhinitis Medicine Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Rhinitis Medicine in 2022
Figure 79. Manufacturing Process Analysis of Rhinitis Medicine
Figure 80. Rhinitis Medicine Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • アレルギー性鼻炎治療薬のグローバル市場2023：抗ヒスタミン薬、点鼻ステロイド薬、抗ロイコトリエン薬
  • 抗アレルギー薬のグローバル市場2023：抗ヒスタミン薬、アナフィラキシーメディエーターブロッカー薬、カルシウム薬、免疫抑制薬
  • アレルギー性鼻炎薬のグローバル市場2023-2033：抗ヒスタミン薬、免疫療法、コルチコステロイド、うっ血除去剤、その他
  • ピーナッツアレルギー治療のグローバル市場2023-2030：抗ヒスタミン薬、エピネフリン
  • 乗り物酔い止め薬のグローバル市場2023-2027：抗ヒスタミン薬、抗コリン薬
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR23AG11545 )"鼻炎薬のグローバル市場2023：抗ヒスタミン薬、点鼻ステロイド薬、抗ロイコトリエン薬" (英文：Global Rhinitis Medicine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。